BSP:PFIZ34 (USA)  
Pfizer Inc logo

Pfizer Inc

R$ 65.04 (-2.59%) Dec 6
P/E:
9.56
P/B:
3.01
Market Cap:
R$ 1.46T ($ 279.98B)
Enterprise V:
R$ 1.47T ($ 282.17B)
Volume:
6.29K
Avg Vol (2M):
21.08K
Also Trade In:
Volume:
6.29K
Market Cap R$:
1.46T
Market Cap $:
279.98B
PE Ratio:
9.56
Avg Vol (2-Month):
21.08K
Enterprise Value R$:
1.47T
Enterprise Value $:
282.17B
PB Ratio:
3.01

Business Description

Description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.